Zika Virus: Information For Providers
Indications for Zika Virus Testing
As of December 31, 2018, the Indiana State Department of Health (ISDH) Laboratories will no longer be offering Zika virus testing. Testing for Zika virus is now available from multiple commercial laboratories. Health care providers wishing to request Zika virus testing are encouraged to communicate with their laboratory about the best way to order commercial testing.
As a reminder, the CDC recommends Zika virus testing for:
- Anyone with possible Zika virus exposure (living in, traveling to, or having unprotected sex with someone who lives in or traveled to an area with risk of Zika) who has or has recently experienced symptoms of Zika
- Symptomatic pregnant women with possible Zika virus exposure
- Asymptomatic pregnant women with ongoing (daily or weekly) Zika virus exposure
- Pregnant women with possible Zika virus exposure who have a fetus with prenatal ultrasound findings consistent with congenital Zika virus infection
Testing of asymptomatic pregnant women without ongoing exposure is no longer routinely recommended to address the increased probability of false positive results in the setting of declining prevalence of Zika virus disease. Health care providers may consider testing of asymptomatic pregnant women on a case-by-case basis using a shared physician-patient decision-making model.
For more information on Zika virus testing recommendations, please visit the CDC Testing Guidance page.
Zika Resources for Clinicians
Free Continuing Education (CE): Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection — US Territories and Freely Associated States, 2018
For more information for healthcare providers, please visit the CDC Healthcare Provider page.
For questions please contact Taryn Stevens, Zoonotic and Vector-Borne Epidemiologist, at 317-234-9727.
Page last updated: January 8, 2019
Page last reviewed: August 1, 2016